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Research
Exogenous factors may affect hormonal 
function, and several epidemiologic studies 
in peri- and postmenopausal women have 
suggested that metals alter hormone levels 
(Gallagher et al. 2010; Krieg 2007; Mendola 
et al. 2008; Nagata et al. 2005). However, evi-
dence among premenopausal women is sparse 
(Gerhard et al. 1998; Jackson et al. 2008).
Environmental estrogens act through 
genomic pathways by binding to the estro-
gen receptor and initiating transcription of 
estrogen-activated genes, and through nonge-
nomic pathways that involve signaling ini-
tiated in the cellular membrane (Tilghman 
et al. 2008). Divalent metals, including lead 
and mercury, can initiate the estrogen recep-
tor by interacting with amino acids at the 
receptor binding site (Zhang et al. 2008), 
and both metals exert estrogenic changes 
in experi  mental models (Choe et al. 2003). 
Stoica et al. (2000) reported that cadmium 
may obstruct the hormone-binding domain 
of the estrogen receptor-α, thereby affecting 
subsequent transcriptional processes (Guével 
et al. 2000), but Silva et al. (2006) reported 
that cadmium did not have estrogenic prop-
erties based on other assays. Cross-sectional 
data are inadequate to assess hormonal pat-
terns during the menstrual cycle (Howards 
et al. 2009), especially in association with 
environmental exposures that may alter hor-
mone levels at certain times of the menstrual 
cycle but not others. Traditional approaches 
fail to capture the multiple physiologic 
parameters during a regular menstrual cycle 
and do not account for the complex interplay 
among reproductive hormones, for which 
traditional methods to control for confound-
ing are inadequate. Further, evaluating hor-
monal differences from the peak to nadir and 
shifts in hormonal peaks can provide valu-
able insight into subclinical changes in hor-
monal function. Hormonal alterations may 
increase anovu  lation, with effects on fertility 
(Aksel et al. 1976; Lutoslawska et al. 2006), 
but anovu  la  tion has not been assessed among 
women who have been exposed to metals.
Our objective in the present study was 
to estimate associations between biomark-
ers of metal exposures (cadmium, lead, and 
mercury) and a) patterns of reproductive 
hormones [estradiol, progesterone, luteiniz-
ing hormone (LH), and follicle-stimulating 
hormone (FSH)], including mean change, 
amplitude, and phase shift across the cycle; 
b) mean change in reproductive hormones 
over the menstrual cycle while accounting for 
dependence between hormones; and c) anovu-
lation among healthy, premenopausal women.
Materials and Methods
Study participants. The BioCycle Study 
enrolled 259 healthy, regularly menstruating 
women (18–44 years of age) for up to two 
cycles to determine associations among bio-
markers of oxidative stress, antioxidants, and 
hormonal levels during the menstrual cycle 
(Wactawski-Wende et al. 2009). Women 
who self-reported a menstrual cycle length 
between 21 and 35 days, who were not try-
ing to conceive, and who had not used hor-
monal contraception in the past 3 months 
were included in the study. Women were 
followed prospectively for one (n = 9) or 
two (n = 250) menstrual cycles. The present 
analysis includes 252 women. Metals were 
measured from a single whole-blood sample 
that was collected at enrollment, and hor-
mones were measured in blood samples col-
lected up to eight times per cycle, with 94% 
of women completing seven or eight clinic 
visits per cycle. Data collection occurred from 
2005 to 2007 at the University at Buffalo in 
New York. The University at Buffalo Health 
Sciences Institutional Review Board (IRB) 
approved the study, and all participants pro-
vided written informed consent. Under a reli-
ance agreement, the National Institutes of 
Health depends on the designated IRB of   
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Ba c k g r o u n d: Metals can interfere with hormonal functioning by binding at the receptor site and 
through indirect mechanisms; thus, they may be associated with hormonal changes in premeno-
pausal women.
oBjectives: We examined the associations between cadmium, lead, and mercury, and anovula-
tion and patterns of reproductive hormones [estradiol, progesterone, follicle-stimulating hormone 
(FSH), luteinizing hormone] among 252 premenopausal women 18–44 years of age who were 
enrolled in the BioCycle Study in Buffalo, New York.
Me t h o d s : Women were followed for up to two menstrual cycles, with serum samples collected up to 
eight times per cycle. Metal concentrations were determined at baseline in whole blood by inductively 
coupled mass spectroscopy. Marginal structural models with stabilized inverse probability weights 
and nonlinear mixed models with harmonic terms were used to estimate the effects of cadmium, lead, 
and mercury on reproductive hormone levels during the menstrual cycle and anovulation.
re s u l t s: Geometric mean (interquartile range) cadmium, lead, and mercury levels were 0.29 
(0.19–0.43) μg/L, 0.93 (0.68–1.20) μg/dL, and 1.03 (0.58–2.10) μg/L, respectively. We observed 
decreases in mean FSH with increasing cadmium [second vs. first tertile: –10.0%; 95% confidence 
interval (CI), –17.3% to –2.5%; third vs. first tertile: –8.3%; 95% CI, –16.0% to 0.1%] and 
increases in mean progesterone with increasing lead level (second vs. first tertile: 7.5%; 95% CI, 
0.1–15.4%; third vs. first tertile: 6.8%; 95% CI, –0.8% to 14.9%). Metals were not significantly 
associated with anovulation. 
co n c l u s i o n s: Our findings support the hypothesis that environmentally relevant levels of metals are 
associated with modest changes in reproductive hormone levels in healthy, premenopausal women.
key w o r d s : anovulation, cadmium, lead, menstrual cycle, mercury, reproductive hormones. 
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the University at Buffalo for review, approval, 
and continuing oversight of its human subject 
research for the BioCycle Study.
Exposure assessment. At the enrollment 
visit, which occurred an average of 16 days 
before the first clinic visit, whole blood was 
collected in purple-top Vacutainer tubes 
(Becton, Dickinson and Company, Franklin 
Lakes, NJ) that contained EDTA and that 
were prescreened for trace metals. After the 
samples were collected, they were refriger-
ated and later sent to the CDC’s Division 
of Laboratory Sciences, National Center for 
Environmental Health, for lead, cadmium, 
and mercury assessment by inductively cou-
pled plasma mass spectrometry. Mercury 
levels represent the total concentration of 
mercury in blood from all relevant forms of 
mercury (e.g., inorganic, methyl). The lim-
its of detection (LODs) for cadmium, lead, 
and mercury were 0.20 μg/dL (25% < LOD), 
0.25 μg/dL (0% < LOD), and 0.30 μg/dL 
(12% < LOD). Lab-reported values < LOD 
were used without substitution to minimize 
potential bias (Craig et al. 2003; Richardson 
and Ciampi 2003; Schisterman et al. 2006).
Biospecimen collection. Fasting blood 
samples for hormone measurements were col-
lected in the morning to minimize diurnal 
variation. Participants used Clearblue Easy fer-
tility monitors (Inverness Medical, Waltham, 
MA) to assist in scheduling midcycle visits 
(Howards et al. 2009), beginning on the sixth 
day after the start of menses and continuing 
daily testing until either the monitor indi-
cated an LH surge or 20 test days had passed. 
If the monitor indicated peak fertility, the 
woman was instructed to come into the clinic 
that day and the next 2 days. Other visits 
were scheduled based on an algorithm that 
considered women’s reported cycle length. 
Visits were timed to correspond to early men-
struation, mid- and late follicular phase, twice 
around expected ovulation, and early and late 
luteal phase.
Outcomes assessment. Reproductive 
hormones were measured in fasting serum 
samples collected in red-top tubes with no 
anticoagulant, spun, serum aliquoted, stored at 
–80°C, and shipped in batches that included a 
woman’s complete cycle samples. Estradiol 
was measured with radio  immunoassay. 
Progesterone, LH, and FSH were measured 
using solid-phase competitive chemilumines-
cent enzymatic immunoassays by Specialty 
Laboratory (Valencia, CA) on a DPC 
Immulite 2000 analyzer (Siemens Medical 
Solutions Diagnostics, Deerfield, IL). The 
interassay coefficients of variation reported by 
the laboratory for estradiol, LH, FSH, and 
progesterone were 9.7%, 4.8%, 4.8%, and 
14.1%, respectively.
Cycles were classified as anovulatory if the 
progesterone level was ≤ 5 ng/mL throughout 
the entire cycle and if no serum LH peak was 
observed on the mid- or late-luteal-phase visit 
(Gaskins et al. 2009). Based on this definition, 
42 of the 509 (8%) cycles were considered 
anovulatory, including 24 (57%) that occurred 
during the first cycle and 18 (43%) during the 
second. We also conducted a sensitivity analy-
sis using a less restrictive definition of anovu-
lation based on progesterone across the cycle 
of < 5 ng/g (Abdulla et al. 1983; Malcolm and 
Cumming 2003) that resulted in 65 cycles 
(13%) being classified as anovulatory.
Covariate assessment. At enrollment, 
women provided written consent and then 
were asked to provide a health and reproduc-
tive history and lifestyle information (e.g., 
smoking, alcohol intake), and anthropometric 
measurements were taken by trained staff. In 
addition, usual physical activity was assessed 
using the International Physical Activity 
Questionnaire (IPAQ) (Yang et al. 2004) and 
categorized according to standard IPAQ cut-
points, and a food frequency questionnaire 
was used to estimate usual daily total energy, 
iron, shellfish, fish, and vegetable intakes dur-
ing the previous 6 months (Fred Hutchinson 
Cancer Center, Seattle, WA).
Statistical methods. Descriptive statistics 
for continuous and categorical covariates were 
compared by tertiles of metal exposure and 
ovulatory status using analysis of variance, 
chi-square test, or Fisher’s exact test, as appro-
priate. Hormone levels were natural log trans-
formed for normality. Metals were assessed as 
tertiles and continuous variables. Models were 
run separately for each metal. Potential con-
founders were identified (based on a review 
of the literature) and included age, body mass 
index (BMI), and race (white, black, Asian, 
other). We also evaluated smoking; income; 
education; physical activity; parity; dietary 
iron, fish, shellfish, and vegetables; and total 
calories as potential confounders; these factors 
were not included in the final models because 
they did not alter estimated associations by 
> 10% between metals and hormones or 
anovu  lation. Because of the small number of 
smokers, we restricted the sensitivity analyses 
to nonsmokers. One individual was excluded 
from continuous analyses of cadmium because 
her level was > 3 SDs from the mean.
We used generalized linear mixed mod-
els to estimate the association between metal 
exposures (modeled as continuous variables) 
and anovu  lation while accounting for depen-
dence within women and cycles using SAS 
(version 9.2; SAS Institute Inc., Cary, NC). 
With these models, inferences are subject spe-
cific; the odds ratios correspond to a change 
in odds of anovu  lation associated with a one-
unit change in blood metal level for an indi-
vidual subject (Zeger et al. 1988).
We used nonlinear mixed effects mod-
els with harmonic terms (version 2.10.1; 
R Foundation for Statistical Computing, 
Vienna, Austria) to evaluate associations 
between metals (grouped according to ter-
tiles) and patterns of reproductive hormones 
over one to two menstrual cycles, account-
ing for cyclical hormonal changes and com-
plex between-subject variation (Albert and 
Hunsberger 2005). Outcomes for each hor-
mone (natural-log–transformed estradiol, 
FSH, LH, and progesterone) included mean 
concentration, amplitude (the difference 
between nadir and peak hormone levels), 
and timing of shifts in the hormonal profile. 
Random effects for models of hormone means 
and amplitudes included a subject-specific 
term and, for each subject, a cycle-specific 
term. The number of harmonic terms used 
in each model was selected to minimize the 
Akaike information criteria (Akaike 1973) 
and to reflect the expected shape of the hor-
monal profile. Time was scaled such that time 
was set to 0 on the first day of an individu-
al’s cycle, 0.5 on the day of ovulation, and 
1.0 on the last day of the cycle, regardless of 
the actual calendar days. Models to estimate 
associations with tertiles of metal exposure 
were run separately for each metal and were 
adjusted for age (continuous), BMI (continu-
ous), and race (white, black, Asian, other).
We used generalized linear mixed mod-
els with stabilized weights to estimate effects 
of metals (continuous) on natural-log– 
transformed hormone levels while appro-
priately accounting for confounding by 
hormone levels at other times during the cycle 
(Cole and Hernan 2008; Robins et al. 2000). 
Inverse probability of treatment weights were 
conditioned upon estradiol, progesterone, 
LH, FSH, race (white, black, Asian, other), 
age, and BMI. Adujsting for smoking (cur-
rent vs. nonsmoker) and average calorie intake 
(continuous) did not appreciably alter the esti-
mates; thus, these factors were not included in 
the final models. An α-level ≤ 0.05 denoted 
statistical significance. We assessed interac-
tions between each pair of metals separately 
with all three metals included in one model 
using a p < 0.10 criterion.
Results
Metal exposure. In Table 1, we summarize 
the BioCycle cohort population characteris-
tics. Mean age of participants was 27 years, 
and mean BMI was 24 kg/m2. Most partici-
pants were white, unmarried, and nulliparous. 
Cadmium and lead were positively associated 
with age, whereas mercury was not. BMI was 
not associated with metal exposures. Higher 
blood cadmium and lead levels were more 
common among nonwhites, whereas blood 
mercury was associated with race—those who 
identified themselves as Asian had the high-
est mercury levels. Smoking was positively 
marginally associated with cadmium but not Pollack et al.
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with lead or mercury. Women with anovula-
tory cycles were more likely to be nulliparous 
and unmarried. Twenty-three participants 
completed the study in nonconsecutive cycles, 
and their demographics were similar to 
those completing the study in consecutive 
cycles. Because metals and hormones were 
right-skewed, we calculated geometric means. 
Cadmium was positively correlated with lead 
(ρ = 0.12, p = 0.04) and mercury (ρ = 0.12, 
p = 0.05). Lead and mercury were not statisti-
cally correlated (ρ = 0.08, p = 0.19).
Pituitary reproductive hormones. Using 
nonlinear mixed models with four harmonic 
terms, cadmium exposure was associated with 
–10% [95% confidence interval (CI), –17.3% 
to –2.5%] and –8.3% (95% CI, –16.0% to 
0.1%) decreased mean FSH levels for the high-
est and middle tertiles, respectively, compared 
with the lowest exposed tertiles (Table 2). 
Cadmium was associated with changes in FSH 
amplitude (peak to nadir difference) of –0.02 
(95% CI, –0.05 to 0.01) and –0.02 (–0.05 
to 0.01) for the highest and middle tertiles, 
respectively, compared with the lowest. Lead 
was associated with increased FSH means 
of 8.0% (95% CI, –0.9% to 17.7%) for the 
middle tertile and 3.6% (95% CI, –5.3% to 
13.3%) for the upper tertile, compared with 
the lowest. Mercury was associated with a 
change in LH for the middle tertile of –11.7% 
(95% CI, –20.0% to –2.5%) compared with 
the lowest. Figure 1 displays the hormonal pat-
terns for estradiol, progesterone, LH, and FSH 
by tertile of metal exposure adjusted for race, 
age, and BMI (plots show tertiles for white 
women of mean age and BMI) and shows a 
decreased mean and amplitude for FSH in 
relation to cadmium exposure and decreased 
LH for the middle tertile of mercury.
Ovarian reproductive hormones. Using 
nonlinear mixed models with four harmonic 
terms, we observed that metals were not sta-
tistically significantly associated with estradiol 
levels. However, cadmium and lead levels were 
consistently but not statistically significantly 
associated with increased mean and decreased 
amplitude of estradiol levels (Table 2). The 
amplitude for estradiol was decreased, although 
not statistically significant, for increased cad-
mium and lead exposure (Table 2). Mercury 
was not consistently associated with changes in 
direction of estradiol mean, although increas-
ing exposure was associated with delayed rises 
of estradiol of 0.15 (95% CI, 0.01 to –0.29) 
and 0.18 (95% CI, 0.03 to –0.33) equiva-
lent to approximately 3–4 hr. Cadmium and 
lead were not associated with phase shifts in 
estradiol. Mean progesterone was 7.5% (95% 
CI, 0.1–15.4%) higher for participants in the 
middle versus low tertile of lead and 6.8% 
(95% CI, –0.8% to 14.9%) higher for the 
high versus low tertile (Table 2). Lead was 
associated with a delayed rise of progesterone, 
with a 0.15-day shift compared with the low-
est tertile (95% CI, 0.05–0.26). Mercury was 
similarly associated with a later progesterone 
rise, with shifts of 0.09 (95% CI, < –0.01 to 
0.19) and 0.13 (95% CI, 0.03–0.24) days for 
the middle and high tertiles compared with 
the lowest. Cadmium was not consistently 
associated with changes in progesterone mean 
or amplitude.
Marginal structural models. Weighted 
linear mixed models that were adjusted for 
changing hormone levels across the cycle indi-
cated that cadmium, lead, and mercury were 
not statistically significantly associated with 
mean log-transformed estradiol, progesterone, 
LH, or FSH concentrations (Table 3).
Anovulation. Metals were not statisti-
cally significantly associated with anovulation. 
Odds ratios for anovulation per 1 μg/L cad-
mium, 1 μg/dL lead, and 1 μg/L mercury were 
Table 1. BioCycle Study population characteristics, 
Buffalo, New York (2005–2007).
Characteristic
BioCycle Study 
population
Age (mean ± SD) 27.3 ± 8.2
BMI [kg/m2 (mean ± SD)] 24.1 ± 3.9
Calories [kcal/day (mean ± SD)] 1,608 ± 353
Follicular estradiol [pg/mL; 
GM (IQR)]a
33.2 (25.0–43.0)
Midcycle FSH [mIU/mL; 
GM (IQR)]b
6.8 (4.7–10.2)
Midcycle LH [ng/mL; GM (IQR)]b 11.6 (5.6–15.0)
Luteal progesterone [ng/mL; 
GM (IQR)]c
6.2 (4.8–12.2)
Cadmium [μg/L; GM (IQR)]d 0.29 (0.19–0.43)
Lead [μg/dL; GM (IQR)]d 0.93 (0.68–1.20)
Mercury [μg/L; GM (IQR)]d 1.03 (0.58–2.10)
Anovulatory cycles (n)
0 221
1 25
2 6
Race (n)
White 150
Black 51
Asian 36
Other 15
Smoking (n)
No/former 242
Current 10
Marital status (n)
Ever married 80
Physical activity
Low 24
Medium 89
High 139
Parity (n)
Nulliparous 182
Education (n)
> High school 221
IQR, interquartile range.
aGeometric mean estradiol levels (IQR) measured during 
early follicular phase, cycle day 2. bGeometric mean FSH 
and LH levels (IQR) measured during midcycle, cycle day 
13. cGeometric mean progesterone levels (IQR) measured 
during luteal phase, cycle day 22. dGeometric mean (IQR) 
blood metal levels.
Table 2. Nonlinear mixed models with four harmonic terms for metals (low = referent) and natural-log–transformed hormones among women with ovulatory 
cycles (n = 234), BioCycle Study (2005–2007).a
Mean % (95% CI) Amplitude (95% CI) Phase shift [dayb (95% CI)]
Characteristic Medium High Medium High Medium High
Estradiol (pg/mL)
Cadmium (μg/L) 5.5 (–3.5 to 15.5) 5.1 (–4.1 to 15.2) –0.01 (–0.06 to 0.04) –0.02 (–0.06 to 0.05) –0.12 (–0.29 to 0.02)  –0.04 (–0.20 to 0.12)
Lead (μg/dL) 8.2 (–1.2 to 18.6) 4.7 (–4.7 to 15.2) –0.01 (–0.06 to 0.04) –0.02 (–0.7 to 0.03) –0.09 (–0.24 to 0.05) 0.14 (–0.01 to 0.29)
Mercury (μg/L) 5.5 (–3.5 to 15.5) –2.4 (–10.9 to 6.9) 0.02 (–0.02 to 0.07) 0.03 (–0.02 to 0.8) 0.15 (0.01 to 0.29) 0.18 (0.03 to 0.33)
FSH (mIU/mL)
Cadmium (μg/L) –10.0 (–17.3 to –2.5) –8.3 (–16.0 to 0.1) –0.02 (–0.05 to 0.01) –0.02 (–0.05 to 0.01) –0.13 (–0.31 to 0.05) 0.09 (–0.09 to 0.28)
Lead (μg/dL) 8.0 (–0.9 to 17.7) 3.6 (–5.3 to 13.3) –0.01 (–0.03 to 0.02) –0.02 (–0.04 to 0.01) –0.06 (–0.25 to 0.12) –0.02 (–0.21 to 0.18)
Mercury (μg/L) 1.7 (–6.6 to 10.6) –5.1 (–12.9 to 3.4) –0.01 (–0.3 to 0.02) –0.01 (–0.03 to 0.07) 0.15 (–0.03 to 0.33) 0.14 (–0.05 to 0.32)
LH (ng/mL)
Cadmium (μg/L) 7.0 (–3.1 to 18.4) 1.0 (–9.0 to 12.1) –0.02 (–0.05 to 0.01) 0.00 (–0.03 to 0.03) –0.07 (–0.27 to 0.13) –0.03 (–0.23 to 0.17)
Lead (μg/dL) 5.1 (–5.1 to 16.4) –0.5 (–10.5 to 10.7) –0.01 (–0.03 to 0.02) –0.02 (–0.04 to 0.01) –0.16 (–0.36 to 0.03) –0.11 (–0.32 to 0.10)
Mercury (μg/L) –11.7 (–20.0 to –2.5) 0.4 (–9.2 to 11.1) 0.02 (–0.01 to 0.04) –0.02 (–0.05 to 0.01) 0.02 (–0.19 to 0.21) 0.01 (–0.19 to 0.22)
Progesterone (ng/mL)
Cadmium (μg/L) 2.7 (–4.3 to 10.2) –2.3 (–9.2 to 5.1) –0.04 (–0.11 to 0.03) 0.03 (–0.04 to 0.11) –0.07 (–0.18 to 0.03) –0.03 (–0.13 to 0.07)
Lead (μg/dL) 7.5 (0.1 to 15.4) 6.8 (–0.8 to 14.9) 0.07 (0.01 to 0.15) –0.06 (–0.13 to 0.01) 0.04 (–0.06 to 0.15)  0.15 (0.05 to 0.26)
Mercury (μg/L) 1.4 (–5.4 to 8.8) 3.6 (–3.6 to 11.3) 0.01 (–0.06 to 0.09) –0.04 (–0.11 to 0.03) 0.09 (–0.00 to 0.19) 0.13 (0.03 to 0.24)
aTime scale for mean and amplitude results ranged from 0 to 1; time scale for phase shift is a 28-day cycle. Data are adjusted for age (continuous), race (white, black, Asian, other), and 
BMI (continuous). Cadmium tertiles: low, 0.03–0.23 μg/L; medium, 0.24–0.36 μg/L; high, 0.37–3.10 μg/L. Lead tertiles: low, 0.30–0.72 μg/dL; medium, 0.73–1.10 μg/dL; high, 1.11–6.20 μg/dL. 
Mercury tertiles: low, 0.00–0.74 μg/L; medium, 0.75–1.50 μg/L; high, 1.51–9.00 μg/L. bProportion of 24 hr day.Metals, hormones, and anovulation in women
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1.29 (95% CI, 0.20–8.47), 1.20 (95% CI, 
0.62–2.34), and 1.12 (95% CI, 0.85–1.48), 
respectively, adjusted for age, race, and BMI. 
After restricting the analyses to persons who 
had never smoked > 100 cigarettes (n = 195), 
the odds ratios for cadmium, lead, and mer-
cury were 1.66 (95% CI, 0.22–12.30), 0.93 
(95% CI, 0.39–2.91), and 1.07 (95% CI, 
0.79–1.46), respectively. Additional sensitiv-
ity analyses conducted using a less conser-
vative definition of ovulation (progesterone 
≤ 5 ng/mL, n = 65 cycles) yielded consistent 
results, and the odds ratios for cadmium, lead, 
and mercury were 1.39 (95% CI, 0.63–3.07), 
1.50 (95% CI, 0.62–3.60), and 1.29 (95% 
CI, 0.48–3.47).
Discussion
Our findings provide some evidence that 
low levels of metals may be associated with 
modest hormonal variation in healthy, pre-
menopausal women. At environmentally 
relevant levels, we observed a positive asso-
ciation between mean progesterone and lead 
levels above the lowest tertile and declines in 
FSH mean concentration and amplitude with 
cadmium levels above the lowest tertile. The 
combination of increasing mean and decreas-
ing amplitude we observed for lead and FSH 
and evidence of increased mean estradiol with 
cadmium and lead may indicate the start of 
resistance to ovulation, similar to what natu-
rally occurs among perimenopausal women, 
where greater estradiol and FSH levels are 
needed to achieve ovulation (Santoro et al. 
1996). However, we observed no significant 
associations between metals and anovu  lation. 
Our findings highlight the need for additional 
research on ovulatory and hormonal function 
in premenopausal women.
We observed slight differences between 
the marginal structural models and non-
linear mixed models with harmonic terms. 
Nonlinear models enable detection of changes 
in amplitude and phase shift, in addition to 
mean differences. Marginal structural mod-
els assess only mean differences and are less 
efficient because of the weight term. The 
discrepancies could possibly be explained 
by differences in efficiency and the param-
eters assessed between the two approaches. 
Alternatively, time-dependent confounding 
by endogenous hormone levels could explain 
the disparity, because methods to weight har-
monic models have not been developed.
We built upon previous studies that did 
not take timing of hormonal measurements 
into account but suggested a link between 
metal levels and hormones. Our findings 
differed from a study reporting a positive 
association between cadmium and FSH in 
perimenopausal women (Gallagher et al. 
2010). However, our study population was 
premenopausal, and hormonal measurements 
were timed over the course of the menstrual 
cycle, whereas hormone measurements 
in Gallagher et al. (2010) were not timed 
to the menstrual cycle, and cadmium was 
measured in urine reflecting a longer expo-
sure time period than blood. Cadmium lev-
els were lower among BioCycle participants 
(geometric mean, 0.29 μg/L) than among 
Table 3. Weighted linear mixed models of blood cadmium, lead, and mercury (continuous) on reproduc-
tive hormones (natural log transformed) in the BioCycle Study (2005–2007).
Log-transformed 
hormone
Cadmium Lead Mercury
n β-Coefficient 95% CI β-Coefficient 95% CI β-Coefficient 95% CI
Estradiol (pg/mL) 218 0.16 –0.02 to 0.34 0.03 –0.05 to 0.11 0.001 –0.03 to 0.04
FSH (mIU/mL) 218 0.004 –0.14 to 0.15 –0.01 –0.07 to 0.06 0.01 –0.02 to 0.03
LH (ng/mL) 218 0.11 –0.07 to 0.29 0.02 –0.06 to 0.10 0.01 –0.02 to 0.05
Progesterone (ng/mL) 218 –0.01 –0.26 to 0.23 0.06 –0.04 to 0.17 –0.04 –0.08 to 0.01
Data adjusted for BMI (continuous), race (white, black, Asian, other), and age (continuous) and weighted using inverse 
probability of treatment weights.
Figure 1. Metal exposure and reproductive hormone changes in a standardized menstrual cycle with four-
term nonlinear harmonic models, BioCycle Study (n = 234). Cadmium tertiles: low, 0.04–0.23 μg/L; medium, 
0.24–0.36 μg/L; high, 0.37–3.10 μg/L. Lead tertiles: low, 0.30–0.71 μg/dL; medium, 0.72–1.10 μg/dL; high, 
1.11–6.20 μg/dL. Mercury tertiles: low, 0.00–0.74 μg/L; medium, 0.75–1.50 μg/L; high, 1.51–9.90 μg/L.
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similar populations (geometric mean, 0.42 
μg/L) (Jackson et al. 2008), possibly because 
of the low prevalence of smoking (Järup and 
Akesson 2009; Satarug and Moore 2004). 
Further, we conducted sensitivity analyses 
restricting to never smokers and adjusted all 
other analyses for smoking, and the results 
were similar (data not shown). We found that 
lead was positively, although not statistically 
significantly, associated with estradiol, similar 
to previous findings in a case–control study 
of infertility (Chang et al. 2006). Our find-
ings that lead was positively associated with 
progesterone and positively but not statisti-
cally significantly associated with estradiol 
are consistent with a recent study of lead and 
inhibin B, a marker of follicular develop-
ment. In this study, Gollenberg et al. (2010) 
found that high levels of lead were associ-
ated with decreased odds of high inhibin B, 
which indicates a possible pubertal delay. The 
observed association with elevated ovarian 
hormones and lead could possibly indicate 
that greater levels of ovarian hormones are 
necessary for normal reproductive hormonal 
function. In one study of placental metals 
and hormones, Stasenko et al. (2010) found 
no association between lead and progester-
one. Our findings that suggest a positive asso-
ciation between progesterone and lead differ 
from those of studies of higher levels of lead 
exposure in monkeys that showed inverse 
associations with progesterone (Foster et al. 
1996; Laughlin et al. 1987). A cross-sectional 
study of women with repeated miscarriage 
reported that follicular-phase estradiol was 
positively associated with mercury and lead 
(Gerhard et al. 1998), and our findings were 
similar for lead, although not statistically sig-
nificant. Our study suggests that environmen-
tal exposures to metals may be associated with 
modest hormonal effects in healthy, regu-
larly menstruating women, a population not 
often assessed in relation to environmental or 
  hormonal outcomes.
Experimental evidence supports our find-
ings of a positive association between lead and 
mean progesterone and an inverse association 
between cadmium and mean FSH. Evidence 
suggests that lead affects the hypothalamic– 
pituitary–gonadal axis by diminishing expres-
sion of the steroidogenic acute regulatory 
protein gene (Srivastava et al. 2004). Further, 
lead exposure to ovarian granulosa cells induces 
peptides related to proliferation (cyclin B1) 
and apoptosis (caspace-3) (Kolesarova et al. 
2010). P450 cholesterol side chain cleavage 
plays a role in progesterone synthesis, and lead 
could influence progesterone via this mecha-
nism (Zhang and Jia 2007). Our findings that 
cadmium was associated with decreased FSH 
mean and amplitude are consistent with find-
ings that cadmium may inhibit P450 choles-
terol side chain cleavage (Kawai et al. 2002), 
thereby disrupting ovarian hormone synthesis 
or, alternatively, findings that cadmium may 
interact directly with the estrogen receptor 
(Garcia-Morales et al. 1994).
Women who participated in BioCycle 
were not occupationally exposed to metals or 
otherwise highly exposed. Cadmium exposure 
is primarily due to cigarette smoke, and for 
nonsmoking individuals, exposure is mainly 
from diet, particularly from consuming shell-
fish, organ meats, leafy vegetables, and grains 
grown in soil contaminated with cadmium 
(Groten and van Bladeren 1994). Exposure 
tends to vary by race/ethnicity (Mijal and 
Holzman 2010). Cadmium is stored in the 
kidney, and when measured in urine its half-
life is estimated between 15 and 30 years, 
compared with several months in blood; 
thus, differences between our study and oth-
ers may be attributable to quantifying expo-
sure reflecting different time periods [Agency 
for Toxic Substances and Disease Registry 
(ATSDR) 1999b]. Although lead exposure 
in the United States has declined in recent 
years, it remains widespread and comes from 
inhalation and ingestion (Pirkle et al. 1994; 
Mielke and Reagan 1998). Lead is stored 
for years to decades in bone, and in blood 
it has an estimated half-life of 1–2 months. 
Blood lead can be thought of as a steady-state 
marker of lead exposure (Rabinowitz 1991; 
Hu et al. 2007). The preponderance of lead 
sequestered in bone, or the lower levels of 
lead exposure among the study participants 
compared with previous studies that focused 
on older and more highly exposed popula-
tions, may explain our modest findings in 
relation to lead exposure. Although inorganic 
mercury is stored in the kidney, methylmer-
cury passes through the blood–brain barrier, 
is stored in body tissues, and has an estimated 
half-life of 2–4 months (Aberg et al. 1969); 
fish consumption is the primary exposure 
source (ATSDR 1999a). Although measur-
ing metals in blood reflects exposure on the 
order of months, these exposures are likely 
to reflect a steady state of diet and ambi-
ent exposures. Our modest findings may be 
attributable to the limited range of exposure 
among BioCycle participants. Lead and mer-
cury levels in our study were lower than lev-
els reported in premenopausal women in the 
National Health and Nutrition Examination 
Survey (NHANES 1999–2002) in New York 
(geometric mean: 0.87 vs. 1.79 μg/dL for 
lead, and 1.10 vs. 2.73 μg/L for mercury) 
(Jackson et al. 2008). These differences could 
be due in part to lower smoking prevalence 
among BioCycle participants [4% vs. national 
average 25% (Mijal and Holzman 2010)]. 
Geometric mean cadmium levels in BioCycle 
participants, however, were similar to those 
among never-smoking premenopausal women 
in NHANES (0.30 vs. 0.29 μg/L) (Mijal and 
Holzman 2010). Alternatively, rigorous selec-
tion for women with normal reproductive 
function, although intended to minimize con-
founding, may have omitted women with 
greater levels of metals, if such associations 
were present, indicating that stronger asso-
ciations may be seen in other populations. 
Further, to determine if metal exposure was 
associated with completing follow-up in con-
secutive cycles, we examined whether the 
distribution of metals differed among the 
23 women with nonconsecutive cycles and 
found no differences in the results.
Our work was subject to several limitations. 
Assessing metals in blood generally provides 
short-term exposure history. Cadmium meas-
ured in urine is widely accepted as a marker 
of long-term exposure (ATSDR 1999b). 
However, because we believe that women who 
participated in the BioCycle Study had envi-
ronmental exposures to metals that likely came 
from inhalation and diet, their short-term bio-
marker levels may represent a steady state of 
exposure. Further, detecting modest hormonal 
effects is difficult in premenopausal women 
because of endogenous hormonal variation, 
a challenge inherent to studying women of 
reproductive age. However, the use of fertil-
ity monitors improved our ability to capture 
phases of the menstrual cycle with maximal 
hormonal variability. We cannot rule out 
possible unmeasured confounding factors, 
particularly for status of cadmium and iron 
(Vahter et al. 2002), an essential metal that 
we did not measure. Iron could be considered 
a confounder because cadmium update in the 
gastro  intestinal tract is inversely related to iron 
levels, and iron levels are associated with hor-
mone levels. Although our use of weighted 
models appropriately accounted for possible 
time-varying confounding factors affected by 
prior exposure, these models are less precise, 
which may explain why those results were not 
statistically significant. Further, our results 
may not be broadly generalizable, because 
the BioCycle Study represented a highly 
selected population.
To the best of our knowledge, this is the 
first study to assess anovu  lation and repro-
ductive hormone levels over time in relation 
to metal exposure in healthy, premenopausal 
women. We measured metals and hormones 
using the most accurate and precise meth-
ods available, and we measured reproductive 
hormones at multiple well-timed visits across 
two menstrual cycles. Further, we selected 
women for the BioCycle Study to include an 
ethnically diverse, healthy population, with 
no reported history of a range of reproductive 
health conditions, minimizing the impact of 
factors known to be associated with reproduc-
tive function. Information was available on 
multiple potential confounding factors. In 
addition, we used methods to evaluate specific Metals, hormones, and anovulation in women
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components of the hormonal profile and 
compared those results with weighted linear 
mixed models that account for time-  varying 
confounding affected by prior exposures. 
These analytical tools represent an improve-
ment over previous studies in evaluation of 
hormonal patterns across the menstrual cycle 
and provide information on various param-
eters of the hormonal profile. Future work 
to develop nonlinear mixed effects models 
that account for time-varying confounding 
factors will improve our understanding of the 
interplay between reproductive hormones and 
chemical exposures in premenopausal women.
Conclusions
We demonstrated that lead levels above the 
lowest tertile were associated with higher 
mean progesterone levels, whereas cadmium 
levels above the lowest tertile was associ-
ated with decreased FSH mean and ampli-
tude. We observed these associations among 
healthy, regularly menstruating women at 
environmentally relevant exposure levels. 
Because hormone levels in women are con-
sidered risk factors for cardiovascular disease 
(Rossouw et al. 2002) and breast and ovarian 
cancer (Brinton et al. 1988), understanding 
how endogenous levels of metals contribute 
to variation in reproductive hormone levels 
provides additional insight and opportunities 
for prevention. To our knowledge, this is the 
first study to examine anovu  lation in relation 
to metal exposures. Additional research on 
the effects of metals, including long-term bio-
markers of exposure and longitudinal evalua-
tion of ovulation and hormonal function, in 
premenopausal women is warranted.
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